Carlotta Taddei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carlotta Taddei has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Victor William Pike
Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
2 shared publications - Alain Faivre-Chauvet
Inserm, CNRS, Nantes, France
1 shared publication - Amir R. Jalilian
IAEA, Vienna, Austria
1 shared publication - Antonia Georgieva Denkova
Department of Radiation Science and Technology, Delft University of Technology, Mekelweg 15, 2629 JB Delft, Netherlands
1 shared publication - Antony D. Gee
King’s College London
1 shared publication - Bart Cornelissen
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, the Netherlands.
1 shared publication
Latest Publications
- Open Access
- 8 September 2021
- Published by Springer Nature in EJNMMI Radiopharmacy and Chemistry
- Vol. 6 (1) , 1-16
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.
- 8 September 2021
- Published by Springer Nature in EJNMMI Radiopharmacy and Chemistry
- Vol. 6 (1) , 1-16
Open AccessHighlight selection of radiochemistry and radiopharmacy developments by editorial board
Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.
- 28 July 2020
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 5 (31) , 19557-19564
Rapid and Efficient Synthesis of [11C]Trifluoromethylarenes from Primary Aromatic Amines and [11C]CuCF3
Prior studies have shown that trifluoromethylarenes can be labeled in high molar activities (Am > 200 GBq/μmol) with positron-emitting carbon-11 (t1/2 = 20.4 min) by the reaction of the copper(I) derivative of [11C]fluoroform [11C]CuCF3, with several types of precursors, such as aryl iodides, arylboronic acids, and aryldiazonium salts. Nonetheless, these precursors can be challenging to synthesize, and in the case of diazonium salts, are unstable. Methods that reduce challenges in precursor preparation for the synthesis of [11C]trifluoromethylarenes are desirable to enhance possibilities for developing biologically relevant 11C-labeled compounds as radiotracers for biomedical imaging with positron emission tomography (PET). Here, we explored the production of no-carrier-added [11C]trifluoromethylarenes from commercially available primary aromatic amines through reactions of [11C]CuCF3 with diazonium salts that were generated in situ. Moderate to high isolated decay-corrected radiochemical yields (RCY) (32–84%) were obtained rapidly (within 2 min) for many para-substituted and meta-substituted primary aromatic amines bearing a halo, methoxy, thiomethyl, hydroxy, nitro, nitrile, carboxyl, ethylcarboxy, or trifluoromethyl substituent. Null to low RCYs (0–13%) were observed only for ortho bromo-, nitro-, or nitrile-substituted precursors. This new radiosynthetic method usefully expands options for producing PET radiotracers bearing a [11C]trifluoromethyl group, especially from aryl amine precursors.
- 28 July 2020
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 5 (31) , 19557-19564
Rapid and Efficient Synthesis of [11C]Trifluoromethylarenes from Primary Aromatic Amines and [11C]CuCF3
Prior studies have shown that trifluoromethylarenes can be labeled in high molar activities (Am > 200 GBq/μmol) with positron-emitting carbon-11 (t1/2 = 20.4 min) by the reaction of the copper(I) derivative of [11C]fluoroform [11C]CuCF3, with several types of precursors, such as aryl iodides, arylboronic acids, and aryldiazonium salts. Nonetheless, these precursors can be challenging to synthesize, and in the case of diazonium salts, are unstable. Methods that reduce challenges in precursor preparation for the synthesis of [11C]trifluoromethylarenes are desirable to enhance possibilities for developing biologically relevant 11C-labeled compounds as radiotracers for biomedical imaging with positron emission tomography (PET). Here, we explored the production of no-carrier-added [11C]trifluoromethylarenes from commercially available primary aromatic amines through reactions of [11C]CuCF3 with diazonium salts that were generated in situ. Moderate to high isolated decay-corrected radiochemical yields (RCY) (32–84%) were obtained rapidly (within 2 min) for many para-substituted and meta-substituted primary aromatic amines bearing a halo, methoxy, thiomethyl, hydroxy, nitro, nitrile, carboxyl, ethylcarboxy, or trifluoromethyl substituent. Null to low RCYs (0–13%) were observed only for ortho bromo-, nitro-, or nitrile-substituted precursors. This new radiosynthetic method usefully expands options for producing PET radiotracers bearing a [11C]trifluoromethyl group, especially from aryl amine precursors.
- Open Access
- 18 September 2019
- Published by Springer Nature in EJNMMI Radiopharmacy and Chemistry
- Vol. 4 (1) , 1-31
[11C]Carbon monoxide: advances in production and application to PET radiotracer development over the past 15 years
[11C]Carbon monoxide is an appealing synthon for introducing carbon-11 at a carbonyl position (C=O) in a wide variety of chemotypes (e.g., amides, ketones, acids, esters, and ureas). The prevalence of the carbonyl group in drug molecules and the present-day broad versatility of carbonylation reactions have led to an upsurge in the production of this synthon and in its application to PET radiotracer development. This review focuses on the major advances of the past 15 years.
- 18 September 2019
- Published by Springer Nature in EJNMMI Radiopharmacy and Chemistry
- Vol. 4 (1) , 1-31
Open Access[11C]Carbon monoxide: advances in production and application to PET radiotracer development over the past 15 years
[11C]Carbon monoxide is an appealing synthon for introducing carbon-11 at a carbonyl position (C=O) in a wide variety of chemotypes (e.g., amides, ketones, acids, esters, and ureas). The prevalence of the carbonyl group in drug molecules and the present-day broad versatility of carbonylation reactions have led to an upsurge in the production of this synthon and in its application to PET radiotracer development. This review focuses on the major advances of the past 15 years.
- Open Access
- 5 February 2018
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 61 (3) , 237-251
Recent progress in [11C]carbon dioxide ([11C]CO2) and [11C]carbon monoxide ([11C]CO) chemistry
[11C]Carbon dioxide ([11C]CO2) and [11C]carbon monoxide ([11C]CO) are 2 attractive precursors for labelling the carbonyl position (C═O) in a vast range of functionalised molecules (eg, ureas, amides, and carboxylic acids). The development of radiosynthetic methods to produce functionalised 11C‐labelled compounds is required to enhance the radiotracers available for positron emission tomography, molecular, and medical imaging applications. Following a brief summary of secondary 11C‐precursor production and uses, the review focuses on recent progress with direct 11C‐carboxylation routes with [11C]CO2 and 11C‐carbonylation with [11C]CO. Novel approaches to generate [11C]CO using CO‐releasing molecules (CO‐RMs), such as silacarboxylic acids and disilanes, applied to radiochemistry are described and compared with standard [11C]CO production methods. These innovative [11C]CO synthesis strategies represent efficient and reliable [11C]CO production processes, enabling the widespread use of [11C]CO chemistry within the wider radiochemistry community.
- 5 February 2018
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 61 (3) , 237-251
Open AccessRecent progress in [11C]carbon dioxide ([11C]CO2) and [11C]carbon monoxide ([11C]CO) chemistry
[11C]Carbon dioxide ([11C]CO2) and [11C]carbon monoxide ([11C]CO) are 2 attractive precursors for labelling the carbonyl position (C═O) in a vast range of functionalised molecules (eg, ureas, amides, and carboxylic acids). The development of radiosynthetic methods to produce functionalised 11C‐labelled compounds is required to enhance the radiotracers available for positron emission tomography, molecular, and medical imaging applications. Following a brief summary of secondary 11C‐precursor production and uses, the review focuses on recent progress with direct 11C‐carboxylation routes with [11C]CO2 and 11C‐carbonylation with [11C]CO. Novel approaches to generate [11C]CO using CO‐releasing molecules (CO‐RMs), such as silacarboxylic acids and disilanes, applied to radiochemistry are described and compared with standard [11C]CO production methods. These innovative [11C]CO synthesis strategies represent efficient and reliable [11C]CO production processes, enabling the widespread use of [11C]CO chemistry within the wider radiochemistry community.